Affiliation:
1. Federal University of Goias
2. Federal Institute of Sudeste of Minas Gerais – Campus Rio Pomba
3. CORA/HC/UFG/EBSERH), Federal University of Goias
4. University Center of Brasilia
5. Federal University of Ceara
Abstract
Abstract
Purpose
To relate functional performance and kinesiophobia to muscle strength, fatigue and quality of life in women who survivors breast cancer.
Methods
Participated the study 62 women separate into control group (CNT) (age: 52,16 ± 7,59) and breast cancer survivors group (BCS) (age: 52,93 ± 8,95). The functional performance was evaluated by the DASH, the kinesiophobia it was evaluated by the Tampa Scale, quality of life was evaluated EORTC BR-23, fatigue was evaluated FACT B + 4, the muscle strength was evaluated isometric test bilateral and test 1RM. The normality of the data was evaluated by the Komogorov-Smirnov test. Pearson's correlation was used to evaluate the relationship between the variables that presented normal distribution and the Sperman correlation to evaluate the relationship between the variables that did not present normal distribution. The significance level was considered when the p ≤ 0.05
Results.
The BCS group showed worse levels of functional performance (p < 0,001), bilateral isometric strenght (p < 0,001), test 1RM (p = 0,011) and higher levels kinesiophobia than the CNT group (p = 0,005). Bilateral isometric strenght showed a negative correlation with kinesiophobia (r = 0,295; p = 0,019) and functional performance (r= -0,351; p = 0,005). Functional performance showed negative correlaton with fatigue (r= -0,435; p = 0,0004) and quality of life ( -0,296; p = 0,019).
Conclusion.
BCS women have low levels of functional performance, isometric test bilateral, test 1RM and higher levels of kinesiophobia. The functional performance showed negative correlation with bilateral isometric strenght, fatigue and quality of life. The kinesiophobia showed negative correlation with bilateral isometric strenght.
Publisher
Research Square Platform LLC
Reference49 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J for Clin;Bray F,2018
2. Analysis of postoperative radiotherapy effects within risk groups in patients with FIGO I, II, and III endometrial cancer;Popovic V;Indian J of Can,2019
3. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery;Wilke L;Strah. Onkol,2019
4. GLOBOCAN - Global Cancer Observatory. Globocan 2020.
5. Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: A cross-sectional study;Paek J;BMJ Open,2019